Chris Schneck, MD

Professional Titles

• Medical Director, Helen and Arthur E Johnson Depression Center
• Medical Director, CU Medicine Bipolar Clinic

Recognitions

• Top Doctor, 5280 Magazine (2015)
• Top Doctor, 5280 Magazine (2014)
• Top Doctor, 5280 Magazine (2013)
• Top Doctor, 5280 Magazine (2012)
• Top Doctor, 5280 Magazine (2011)
• Top Doctor, 5280 Magazine (2010)
• Top Doctor, 5280 Magazine (2009)
• Top Doctor, 5280 Magazine (2005)
• Top Doctor, 5280 Magazine (2004)
• Top Doctor, 5280 Magazine (2016)
• Top Doctor, 5280 Magazine (2017)
• Top Doctor, 5280 Magazine (2019)
• Top Doctor, 5280 Magazine (2020)

Research Interests

Dr. Schneck’s primary area of interest and research is in bipolar disorder, with a particular emphasis on rapid cycling bipolar disorder and adolescent bipolar disorder.

Publications

• Schneck CD, DelBello MP, Axelson DA, Kowatch RA & Miklowitz DJ. Physician Concordance with a Medication Treatment Algorithm for Adolescent Bipolar Disorder. 9th Annual International Conference On Bipolar Disorders. June, 2011. Pittsburgh, PA. Bipolar Disorders, vol 13, Supp. 1, 2011, p. 86.
• Schneck, CD. Bipolar phenomenology: Have We Learned All We Can Learn? Editorial, Am J Psychiatry 168 (1) :4-6, 2011.
• Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, Dickinson LM, Howe ME, Garber J. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord 2011, 13: 67-75.
• Rothberg B & Schneck CD. Anxiety and Depression. In Textbook of Family Medicine, 8th Edition, Chapter 47, p 1060-1077. Rakel R and Rakel D. Elsevier Press, Philadelphia, 2011.
• Miklowitz, D. J., Schneck, C. D., Singh, M. K., Taylor, D. O., George, E. L., Cosgrove, V. E., Howe, M. E., Dickinson, L M., Garber, J., & Chang, K. D.. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. Journal of the American Academy of Child and Adolescent Psychiatry, vol 52, no.2, 2013: 121-131.
• Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, Cosgrove VE, Howe ME, Dickinson LM, Garber J, Chang KD. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013 Feb;52(2):121-31. PubMed PMID: 23357439
• Miklowitz DJ, Schneck CD, George EL, Taylor DO, Sugar CA, Birmaher B, Kowatch RA, Delbello MP, Axelson DA. Pharmacotherapy and Family-Focused Treatment for Adolescents With Bipolar I and II Disorders: A 2-Year Randomized Trial. Am J Psychiatry. 2014 Mar 14. [Epub ahead of print] PubMed PMID: 24626789
• Miklowitz, DJ, Schneck, CD, George, EL, Taylor, DO, Sugar, CA, Birmaher, B, Kowatch, RA, DelBello, MP and Axelson, DA. A 2-Year Trial of Pharmacotherapy and Family Focused Treatment for Adolescents with Bipolar I and II Disorders. American Journal of Psychiatry, 2014; 171: 658-667.
• Miklowitz DJ, Schneck CD, Birmaher B, DelBello MP & Axelson DA. Response letter to Dr. Parikh. Am J Psychiatry, 2014; 171: 1335-36.
• Shore, J, Vo, A, Yellowlees, P, Waugh, M, Schneck, CD, Nagamoto, H, Thomas, M. Antipsychotic Induced Movement Disorder: Screening Via Telemental Health. Telemedicine and E Health, 2015; in press.
• 4. Schneck CD. Treating Depression and Bipolar Disorder in Integrated Care Settings. In Integrated Behavioral Health and Primary Care: Model and Concept. Robert E Feinstein, Joseph V Connelly and Marilyn Feinstein, eds. Oxford University Press, New York, NY. Expected January, 2017).
• O'Donnell LA, Axelson DA, Kowatch RA, Schneck CD, Sugar CA & Miklowitz DJ. Enhancing quality of life among adolescents with bipolar disorder: a randomized trial of two psychosocial interventions. J Affect Disorders, 2017, 219: 201-208.
• Miklowitz DJ, Schneck CD, Walshaw PD, Garrett AS, Singh MK, Sugar CA, and Chang KD. Early intervention for youth at high risk for bipolar disorder: a multi-site, randomized trial of family focused treatment. Early Intervention in Psychiatry, 2017 Aug 04;0:1-9.
• Schneck CD, Chang KD, Singh MK, DelBello MP and Miklowitz DJ. A pharmacologic algorithm for youth who are at high risk for bipolar disorder. J Child Adolesc Psychopharm. 2017; Vol 27, No. 9: 796-805
• Schneck CD. Treating Depression and Bipolar Disorder in Integrated Care Settings. In Integrated Behavioral Health and Primary Care: Model and Concept. Robert E Feinstein, Joseph V Connelly and Marilyn Feinstein, eds. Oxford University Press, New York, NY. 2017
• O’Donnell LA, Ellis AJ, Van De Loo MM, Stange JP, Axelson DA, Kowatch RA, Schneck CD & Miklowitz DJ. Mood instability as a predictor of clinical and functional outcomes in adolescents with bipolar I and bipolar II disorder. J Affect Disorders, 2018. Vol 236: 199-206.
• Weintraub MJ, Axelson DA, Kowatch RA, Schneck CD & Miklowitz DJ. Comorbid disorders as moderators of response to family interventions among adolescents with bipolar disorder. J Affect Disorders 246:754-762, 2019.
• Coyle RP, Schneck CD, Morrow MM, Coleman SS, Gardner EM, Zheng J-H, Ellison L, Bushman LR, Kiser JJ, MaWhinney S, Anderslon PL & Castillo-Mancilla JR. Engagement in mental health care is associated with higher cumulative drug exposure to antiretroviral therapy. IAPAC International Conference on HIV Treatment and Prevention Adherence. Miami, FL. June, 2018
• Weintraub MJ, Axelson DA, Kowatch RA, Schneck CD, Miklowitz DJ. Comorbid disorders as moderators of response to family interventions among adolescents with bipolar disorder. J Affect Disord. 2019 Mar 1;246:754-762. PubMed PMID: 30623821
• Coyle RP, Schneck CD, Morrow M, Coleman SS, Gardner EM, Zheng JH, Ellison L, Bushman LR, Kiser JJ, Mawhinney S, Anderson PL, Castillo-Mancilla JR. Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy. AIDS Behav. 2019 Dec;23(12):3493-3502. PubMed PMID: 30798457
• Weintraub MJ, Schneck CD, Axelson DA, Birmaher B, Kowatch RA, Miklowitz DJ. Classifying Mood Symptom Trajectories in Adolescents With Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2019 May 28. [Epub ahead of print] PubMed PMID: 31150753
• Lopez A, Schwenk S, Schneck CD, Griffin RJ, Mishkind MC. Technology-Based Mental Health Treatment and the Impact on the Therapeutic Alliance. Curr Psychiatry Rep. 2019 Jul 8;21(8):76. PubMed PMID: 31286280
• Weintraub MJ, Schneck CD, Miklowitz DJ. Network analysis of mood symptoms in adolescents with or at high risk for bipolar disorder. Bipolar Disord. 2019 Nov 15. [Epub ahead of print] PubMed PMID: 31729789
• Hogan J, Boykin D, Schneck CD, Ecker AH, Fletcher TL, Lindsay JA, Shore JH. Clinical Lessons from Virtual House Calls in Mental Health: The Doctor Is in the House. Psychiatr Clin North Am. 2019 Dec;42(4):575-586. PubMed PMID: 31672208
• Miklowitz DJ, Schneck CD, Walshaw PD, Garrett AS, Singh MK, Sugar CA, Chang KD. Early intervention for youth at high risk for bipolar disorder: A multisite randomized trial of family-focused treatment. Early Interv Psychiatry. 2019 Apr;13(2):208-216. PubMed PMID: 28776930
• Weintraub MJ, Schneck CD, Axelson DA, Birmaher B, Kowatch RA, Miklowitz DJ. Classifying Mood Symptom Trajectories in Adolescents With Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Mar;59(3):381-390. PubMed PMID: 31150753
• Zandi PP, Wang YH, Patel PD, Katzelnick D, Turvey CL, Wright JH, Ajilore O, Coryell W, Schneck CD, Guille C, Saunders EFH, Lazarus SA, Cuellar VA, Selvaraj S, Dill Rinvelt P, Greden JF, DePaulo JR. Development of the National Network of Depression Centers Mood Outcomes Program: A Multisite Platform for Measurement-Based Care. Psychiatr Serv. 2020 May 1;71(5):456-464. PubMed PMID: 31960777
• Weintraub MJ, Schneck CD, Miklowitz DJ. Network analysis of mood symptoms in adolescents with or at high risk for bipolar disorder. Bipolar Disord. 2020 Mar;22(2):128-138. PubMed PMID: 31729789
• Weintraub MJ, Schneck CD, Walshaw PD, Chang KD, Singh MK, Axelson DA, Birmaher B, Miklowitz DJ. Characteristics of youth at high risk for bipolar disorder compared to youth with bipolar I or II disorder. J Psychiatr Res. 2020 Apr;123:48-53. PubMed PMID: 32036073
• Miklowitz DJ, Schneck CD, Walshaw PD, Singh MK, Sullivan AE, Suddath RL, Forgey Borlik M, Sugar CA, Chang KD. Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2020 May 1;77(5):455-463. PubMed PMID: 31940011
• O'Donnell LA, Weintraub MJ, Ellis AJ, Axelson DA, Kowatch RA, Schneck CD, Miklowitz DJ. A Randomized Comparison of Two Psychosocial Interventions on Family Functioning in Adolescents with Bipolar Disorder. Fam Process. 2020 Jun;59(2):376-389. PubMed PMID: 32012257
• Shore JH, Schneck CD, Mishkind MC. Telepsychiatry and the Coronavirus Disease 2019 Pandemic-Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care. JAMA Psychiatry. 2020 May 11. [Epub ahead of print] PubMed PMID: 32391861
• Miklowitz DJ, Merranko JA, Weintraub MJ, Walshaw PD, Singh MK, Chang KD, Schneck CD. Effects of family-focused therapy on suicidal ideation and behavior in youth at high risk for bipolar disorder. J Affect Disord. 2020 Oct 1;275:14-22. PubMed PMID: 32658817
• Novick AM, Scott AT, Neill Epperson C, Schneck CD. Neuropsychiatric effects of tamoxifen: Challenges and opportunities. Front Neuroendocrinol. 2020 Oct;59:100869. PubMed PMID: 32822707
• Mishkind MC, Shore JH, Schneck CD. Telemental Health Response to the COVID-19 Pandemic: Virtualization of Outpatient Care Now as a Pathway to the Future. Telemed J E Health. 2020 Dec 8. [Epub ahead of print] PubMed PMID: 33297849
• Fristad MA, Bell Z, Dopp R, Ghaziuddin N, Leffler J, Schneck CD, Singh MK, Sullivan A, Weinstein S, Miller L. Letter to the Editor: Measurement-Based Care in Youth-Feasibility and Acceptance. J Child Adolesc Psychopharmacol. 2020 Dec 31. [Epub ahead of print] PubMed PMID: 33395355
• Mishkind MC, Shore JH, Bishop K, D'Amato K, Brame A, Thomas M, Schneck CD. Rapid Conversion to Telemental Health Services in Response to COVID-19: Experiences of Two Outpatient Mental Health Clinics. Telemed J E Health. 2020 Dec 28. [Epub ahead of print] PubMed PMID: 33393857
• Shore JH, Schneck CD, Mishkind M, Caudill R, Thomas M. Advancing Treatment of Depression and Other Mood Disorders Through Innovative Models of Telepsychiatry. Focus (Am Psychiatr Publ). 2020 Apr;18(2):169-174. PubMed PMID: 33162854
• Weintraub MJ, Keenan-Miller D, Schneck CD, Forgey Borlik M, Suddath RL, Marvin SE, Singh MK, Chang KD, Miklowitz DJ. Social impairment in relation to clinical symptoms in youth at high risk for bipolar disorder. Early Interv Psychiatry. 2021 Feb 8. [Epub ahead of print] PubMed PMID: 33559355
• Weintraub MJ, Schneck CD, Singh MK, Walshaw PD, Chang KD, Sullivan AE, Miklowitz DJ. Longitudinal relationship between maternal distress and pediatric mood symptoms in youth with mood disorders. J Psychiatr Res. 2021 Dec;144:353-359. PubMed PMID: 34735839
• Weintraub MJ, Schneck CD, Posta F, Merranko J, Chang KD, Singh MK, Miklowitz DJ. Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder. J Consulting and Clin Psychology. 2021
• Miklowitz DJ, Weintraub MJ, Singh MK, Walshaw PD, Merranko JA, Birmaher B, Chang KD, Schneck CD. Mood instability in youth at high risk for bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2021.
• Weintraub MJ, Schneck CD, Posta F, Merranko JA, Singh MK, Chang KD, Miklowitz DJ. Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder. J Consult Clin Psychol. 2022 Feb;90(2):161-171. PubMed PMID: 35084893
• Miklowitz DJ, Weintraub MJ, Singh MK, Walshaw PD, Merranko JA, Birmaher B, Chang KD, Schneck CD. Mood Instability in Youth at High Risk for Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2022 Oct;61(10):1285-1295. PubMed PMID: 35307538
• Weintraub MJ, Keenan-Miller D, Schneck CD, Forgey Borlik M, Suddath RL, Marvin SE, Singh MK, Chang KD, Miklowitz DJ. Social impairment in relation to clinical symptoms in youth at high risk for bipolar disorder. Early Interv Psychiatry. 2022 Jan;16(1):17-25. PubMed PMID: 33559355
• 50. Kaiser RH, Peterson EC, Moser A, Neilson C, Hough C, Rosenberg B, Sandman C, Schneck CD, Miklowitz DJ, Friedman NP. Mood symptom dimensions and developmental differences in neurocognition in adolescence. Clinical Psychological Sciences. 2022. In press.
• 51. Miklowitz DJ, Weintraub MJ, Schneck CD, Chang KD, Walshaw PD, Garrett AS and Singh MK. Early intervention for youth at risk for bipolar disorder: psychosocial and neural mediators of outcome. Current Neuropharmacology. 2022. In press.
• Fassett-Carman AN, Moser AD, Ruzic L, Neilson C, Jones J, Barnes-Horowitz S, Schneck CD, Kaiser RH. Amygdala and nucleus accumbens activation during reward anticipation moderates the association between life stressor frequency and depressive symptoms. J Affect Disord. 2023 Jun 1;330:309-318. PubMed PMID: 36871909
• Davis RA, Branagan T, Schneck CD, Schold JD, Thant T, Kaplan B. Lithium and the living kidney donor: Science or stigma?. Am J Transplant. 2023 Sep;23(9):1300-1306. PubMed PMID: 37236400
• Kaiser RH, Moser AD, Neilson C, Jones J, Peterson EC, Ruzic L, Rosenberg BM, Hough CM, Sandman C, Schneck CD, Miklowitz DJ. Neurocognitive risk phenotyping to predict mood symptoms in adolescence. J Psychopathol Clin Sci. 2024 Jan;133(1):90-102. PubMed PMID: 38059934
• Niciu MJ, Meisner RC, Carr BR, Farooqui AA, Feifel D, Kaplin A, Kendrick EJ, Kim PM, Schneck CD, Vande Voort JL, Parikh SV. National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder. J Affect Disord. 2024 Feb 1;346:221-222. PubMed PMID: 37940059
• Kaiser RH, Moser AD, Neilson C, Peterson EC, Jones J, Hough CM, Rosenberg BM, Sandman CF, Schneck CD, Miklowitz DJ, Friedman NP. Mood Symptom Dimensions and Developmental Differences in Neurocognition in Adolescence. Clin Psychol Sci. 2023 Mar;11(2):308-325. PubMed PMID: 37309523
• Miklowitz DJ, Weintraub MJ, Walshaw PD, Schneck CD, Chang KD, Merranko J, Garrett AS, Singh MK. Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome. Curr Neuropharmacol. 2023;21(6):1379-1392. PubMed PMID: 36635932

Practice Locations

Helen and Arthur E Johnson Depression Center - CU Anschutz Medical Campus
1890 N Revere Ct
Anschutz Health Sciences Bldg, Suite 5240
Aurora, CO 80045
303-724-3300

CU Medicine Psychiatry - Outpatient Clinic
1890 N Revere Ct
Anschutz Health Sciences Bldg, Suite 4020
Aurora, CO 80045
303-724-1000

Hospital Affiliation

• University of Colorado Hospital

Center Affiliations

• Depression Center

Specialty Information

Specialties

• Psychiatry, Board Certification (1995, 2015)

Conditions & Treatments

• Mental Health and Behavior - Bipolar Disorder
• Mental Health and Behavior
• Mental Health and Behavior - Depression
• Mental Health and Behavior - Mood and Anxiety